Company intelligence / Profile preview

JIC Genesis

Norwich, Norfolk, United Kingdom

Ownership: Private
Development stage: Other

Overview

JIC Genesis is a specialized investment and company-creation vehicle focused on translating research from the John Innes Centre (JIC) into commercial biotechnology ventures. The entity operates as a partnership between the John Innes Centre and Genesis Genetics (or similar investment partners) to identify, fund, and scale high-impact agricultural and life science technologies. Its primary focus includes crop improvement, plant-based production systems, and microbial natural products. By bridging the gap between academic discovery and industrial application, JIC Genesis aims to address global challenges in food security and sustainable healthcare.

Industry: Investors

Partnerships

John Innes Centre

Beyond the preview

Go deeper on JIC Genesis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JIC Genesis.

Explore the full profile